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Abstract
Background: Overviews of systematic reviews are a relatively new approach to synthesising evidence, and research
methods and associated guidance are developing. Within this paper we aim to help readers understand key issues
which are essential to consider when taking the first steps in planning an overview. These issues relate to the
development of clear, relevant research questions and objectives prior to the development of an overview protocol.
Methods: Initial discussions and key concepts for this paper were formed during a workshop on overview methods
at the 2016 UK Cochrane Symposium, at which all members of this author group presented work and contributed
to wider discussions. Detailed descriptions of the various key features of overviews and their different objectives
were created by the author group based upon current evidence (Higgins J, Green S. Cochrane Handbook Syst Rev
Interv. 2011;4:5, Pollock M, et al. Sys Rev. 2016;5:190-205, Pollock A, et al. Cochrane overviews of reviews: exploring
the methods and challenges. UK and Ireland: Cochrane Symposium; 2016, Pieper D, et al. Res Syn Meth. 2014;5:187–
99, Lunny C, et al. Sys Rev. 2016;5:4-12, Hartling L, et al. Comparing multiple treatments: an introduction to
overviews of reviews. In 23rd Cochrane Colloquium; 2015, Hartling L, et al. Plos One. 2012;7:1-8, Ballard M,
Montgomery P. Res Syn Meth. 2017;8:92-108) and author experiences conducting overviews.
Results: Within this paper we introduce different types of overviews and suggest common research questions addressed
by these overviews. We briefly reflect on the key features and objectives of the example overviews discussed.
Conclusions: Clear decisions relating to the research questions and objectives are a fundamental first step during the
initial planning stages for an overview. Key stakeholders should be involved at the earliest opportunity to ensure that the
planned overview is relevant and meaningful to the potential end users of the overview. Following best practice in
common with other forms of systematic evidence synthesis, an overview protocol should be published, ensuring
transparency and reducing opportunities for introduction of bias in the conduct of the overview.
Keywords: Overview, Systematic review, Evidence synthesis
Background
It is estimated that around 22 new systematic reviews
are published every day [1]. In order to keep pace with
the increasing volume of reviews, new methodological
approaches have been developed for synthesising this
evidence including overviews (systematic reviews of
systematic reviews). Overviews are most frequently
employed where multiple systematic reviews already
exist on similar or related topics, and aim to systematic-
ally bring together, appraise and synthesise the results of
related systematic reviews. Overviews have evolved to
address a growing need to filter the information
overload, improve access to targeted information and
inform healthcare decision-making [2, 3]. Overviews can
be useful tools to support decision-making by clinicians,
policy makers and developers of clinical guidelines [2, 4].
There are a range of factors to reflect upon prior to
deciding whether to conduct an overview, including con-
sideration of the methodological challenges and* Correspondence: h.a.hunt@exeter.ac.uk1Exeter Test Group and PenCLAHRC, University of Exeter Medical School, St
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uncertainties. These challenges are discussed in depth in
our accompanying paper on this topic [5].
Overviews are known by a variety of different names,
all potentially reflecting different aspects and aims of the
syntheses. Terms used include: overview; umbrella
review; meta-review; (systematic) review of (systematic)
reviews; synthesis of systematic reviews; and summary of
systematic reviews. The common feature of the methods
associated with all of these terms is the fundamental
process of synthesising evidence which is derived, often
exclusively, from systematic reviews. The systematic
review forms the primary ‘unit of analysis’ and is the
basis upon which an overview is built [6].
The term ‘overview of systematic reviews’ (often
shortened to ‘overview’) has gained widespread accept-
ance, and is the term used by Cochrane to describe a
review of systematic reviews published in the Cochrane
Library [7]. We use the term ‘overview’ within this
paper to describe systematic summaries of systematic
review evidence, in line with the most commonly used
terminology.
Overviews can play a role in signposting the reader to
evidence, summarising existing research or highlighting
the absence of evidence [7]. For this reason, overviews can
provide an ‘entry point’ for policy makers and other con-
sumers by summarising broad issues and current know-
ledge around a topic, and directing the reader to more
detailed, fine-grained material contained in component
systematic reviews and primary research [8–10].
Likewise, the involvement of stakeholders at an
early point in planning and conducting an overview
may help in shaping these aims for maximum over-
view impact [2, 11, 12].
Overviews arguably have a valuable role where
evidence relating to a specific topic exists but is
conflicting, bringing together reviews in a transpar-
ent and systematic way and aiding informed decision
making by gathering, appraising and systematically
analysing this evidence. While the evidence synthe-
sised within an overview may be used to generate
new insights and understanding, it is important to note
that overviews are fundamentally a method of bringing to-
gether, summarising and enhancing accessibility of exist-
ing evidence.
Methods
Overviews are a relatively new and emerging method of
summarising evidence, and consequently universally-
accepted guidance for good practice relating to the
conduct of overviews is currently lacking [5, 13–17].
During a 2016 UK Cochrane Symposium workshop
[18] focused on the methods and challenges associ-
ated with overviews, it became apparent that there
was a need to clarify, and distinguish between,
different types of overviews and the objectives which
these overviews addressed. Within this paper, we
therefore describe types of overview and the com-
mon research questions and objectives they address.
Within a second, linked paper [5], we build on this
description of overview types, objectives and research
questions, illustrating this through the use of five exem-
plar overviews, and exploring the impact and implications
of different methodological approaches.
In presenting and discussing common research ques-
tions addressed by overviews with different objectives, and
relating this to real examples in the second paper [5], we
aim to help readers understand important issues to
consider during the first steps to planning an overview.
Research questions and objectives addressed by
overviews
In common with all research, overviews are carried out to
address a clearly-stated research question. When planning
an overview, determining the nature of the initial research
question, and identifying who is asking the question, will
dictate the scope of the overview objective(s). The objec-
tives of an overview may include summarising existing
evidence on a range of different topics, including: inter-
ventions; diagnostic accuracy of medical tests or proce-
dures; prognosis or risk prediction; health equity [19]; or
more qualitative aspects associated with any of the above,
such as patient preference or device acceptability. In
addition to summarising the results of multiple systematic
reviews on related topics, overviews may also be used to in-
vestigate different aspects of questions already tackled by
existing systematic reviews, such as variations in popula-
tion, condition or intervention [10–12]. One example of
this latter approach is provided in an overview which aimed
to synthesise current evidence of the relationship between
sedentary behaviour and health outcomes [20], reporting
variation in results across populations and condition
studied.
The principles which guide development of focussed
clinical questions for systematic reviews remain valid for
the development of research questions for overviews.
Clearly defining the target population and setting, con-
text, intervention, index test or phenomenon of interest,
comparator or reference standard and outcome or treat-
ment decisions are all essential parts of any overview
protocol. The research question and overall overview
objective will dictate the ‘type’ of overview that is
required. This may be an overview of specific types of
systematic review, or of systematic reviews which con-
tain specific types of primary research study.
These defining elements of research questions and
objectives are illustrated in Table 1, and we consider the
objectives of each overview type in more detail below.
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Overviews of intervention reviews
Overviews of intervention reviews should be considered
when the research question relates to the effectiveness
of one or more intervention. Common objectives for
overviews of intervention reviews are detailed below.
To summarise evidence from more than one systematic
review of different interventions for the same condition
or problem
This is the primary purpose of Cochrane Overviews of
Interventions, and a number of overviews of interventions
have been employed to tackle this objective [21–23].
For example, one overview has brought together all
systematic reviews of interventions to improve arm
function in people with stroke [22], whilst another over-
view has summarised systematic reviews of conservative
interventions for the treatment of incontinence in
women [21]. One example of a mixed methods overview
assessed all workplace health promotion interventions
using healthcare or wellbeing outcomes from systematic
reviews of effectiveness, combining these with syntheses
of identified policy documents and research on stake-
holders’ perspectives of workplace intervention pro-
grammes [23].
To summarise evidence from more than one systematic
review of the same intervention for the same condition or
problem where different outcomes are addressed in
different systematic reviews
Overviews of interventions can be used to summarise
evidence assessing different outcomes for the same con-
dition. Generally, systematic reviews should include all
outcomes that are important to people making decisions
about and influenced by an intervention. This includes
the involvement of stakeholders in order to reflect
aspects important to people receiving an intervention
[24], and should be incorporated at the study, review
and overview levels. Not all systematic reviews, however,
focus on a single condition or outcome. For example,
one overview has brought together all systematic reviews
of the use of red cell transfusion to prevent or treat
common complications in people with sickle cell disease,
such as painful crises, stroke and acute chest syndrome
[25]. This overview assessed the prevention of these
complications during high-risk situations such as
surgery, pregnancy or a sub-population identified as at
high risk of a particular complication, such as abnormal
transcranial Doppler and risk of stroke in children.
Another overview summarised the safety of long-acting
beta agonists (regular formoterol or salmeterol) in
children with asthma with outcomes including all-cause
mortality, non-fatal serious adverse events, asthma-
related deaths and asthma-related non-fatal serious
events [26]. This overview was prompted by concerns
raised by two large surveillance studies in adults with
asthma [27, 28] that found an increased risk of asthma-
related mortality in those who took regular salmeterol
and the weaker evidence base for the effectiveness of
long-acting beta agonists in children.
To summarise evidence from more than one systematic
review of the same intervention for different conditions,
problems or populations
The same or similar interventions are often used for differ-
ent conditions or different studies and reviews may focus
on different populations. This type of evidence may be of
interest where more than one patient population is being
addressed, as generalisability of the effect may be more
extensive. One recent example is of an overview of reviews
of cognitive rehabilitation for different cognitive problems
in people with stroke [29].
To summarise evidence about adverse effects of an
intervention from more than one systematic review of
use of the intervention for one or more conditions
Systematic reviews often report information on adverse
effects, but few reviews are conducted with the main aim
to report rates of these events. This may well change
following the recent publication of the PRISMA harms
checklist [30]. Due to the rarity of many adverse events,
randomised controlled trials rarely contain sufficient data
to give an accurate indication of prevalence [31, 32]. It
would therefore be inappropriate to rely on systematic
reviews based solely on trial data to profile adverse events
of a specific intervention, except in the rare situations
where the recording of adverse effects data is the primary
aim of the trial [33]. It may be appropriate to include data
not previously included in a systematic review such as
when conducting a Health Technology Assessment (HTA)
report, developing a clinical practice guideline or develop-
ing resources such as BMJ Clinical Evidence. One over-
view summarising evidence on adverse effects of herbal
medicines across all conditions takes this broader
approach to systematic review evidence and provides an
example of methodological challenges encountered [34].
Overviews of diagnostic test accuracy reviews
Overviews of diagnostic test accuracy reviews should be
considered when the research question relates to the
accuracy of one or more diagnostic test. Common objec-
tives for overviews of diagnostic test accuracy reviews
are addressed below.
To summarise evidence from more than one systematic
review of diagnostic test accuracy assessing the same
medical test to address the same condition or problem
The purpose of diagnostic test accuracy overviews is to
form a summary of systematic review evidence in order
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to address a specific research question, where the unit of
interest is systematic reviews of diagnostic test accuracy.
These systematic reviews are designed to assess existing
evidence of the diagnostic accuracy of a test or device
using standard measures of accuracy (sensitivity and
specificity) rather than measures of effectiveness as with
reviews of interventions. Systematic reviews of diagnos-
tic test accuracy commonly encounter greater hetero-
geneity than intervention reviews, due to variation in
study populations, in the testing environment and con-
text, or in procedures used to conduct the tests involved
[35]. Overviews of diagnostic test accuracy which aim to
assess the accuracy of a single medical test generally
have more potential for identifying sources of heterogen-
eity than overviews which address a number of
additional variables such as multiple tests or devices
[35]. An example in which this approach has been taken
is the overview of systematic review evidence of the
diagnostic accuracy of endoscopic ultrasonography
(EUS) for the preoperative loco-regional staging of
primary gastric cancer [36]. The authors reported that
substantial heterogeneity may have influenced the
applicability of clinical usefulness for endoscopic ultra-
sonography for pre-operative loco-staging of primary
gastric cancer [36]. By undertaking an overview, the au-
thors were able to identify the need for greater under-
standing of the sources of heterogeneity before
recommendations could be made about the clinical
usefulness of EUS. Overview authors were also able to
make more nuanced practice recommendations on test
performance, and this ability to pinpoint specific areas
for further research as well as issue practice guidance
demonstrates a potential benefit of overviews.
To summarise evidence from more than one systematic
review of diagnostic test accuracy assessing different
medical tests to address the same condition or problem
Overviews assessing the diagnostic test accuracy of dif-
ferent medical tests addressing the same condition are
similar in terms of scope and objectives to the overviews
described in the previous section, with the key difference
that a number of different medical tests are being
assessed within included systematic reviews. For ex-
ample, a recently-conducted overview summarising the
diagnostic test accuracy of brief cognitive assessments
for identifying dementia in a primary care population
[37] included evidence from a range of systematic re-
views of diagnostic test accuracy of a number of
different brief cognitive assessments. This enabled con-
clusions to be drawn about the accuracy of specific tests
within the primary care population, and signposted a
gap in current evidence for direct comparisons of the
diagnostic accuracy of individual tests for identifying
dementia in primary care. Again, these broader
recommendations were made possible through the wider
synthesis of existing evidence than had previously been
conducted in this specific setting.
Overviews of reviews of prognosis/prevalence
Overviews of reviews of prognosis/prevalence should be
considered when the objective is to summarise evidence
about prognosis/prevalence from more than one system-
atic review. The implementation of overview methodology
in this field is relatively recent, but there are a growing
number of systematic reviews specifically investigating the
predictive value of tests and devices, prognostic informa-
tion and/or prognostic models. These address questions
such as ‘what is the most likely course of this health
condition?’ ‘What factors are associated with outcome?’
and ‘are there risk groups likely to have different out-
comes?’ [38]. One example of such an overview evaluated
the prognostic evidence alongside evidence on treatment,
harms, diagnosis, classification and outcomes used for
managing neck pain [39].
Overviews of reviews of risk factors
These overviews incorporate disease aetiology or risk
factors when the risks of interest may not directly relate
to prognostic variables or risk prediction models. When
planning to conduct an overview of systematic review
evidence in order to explore the effect of putative risk
factors on a range of variables, factors to consider
include whether the primary interest in conducting the
overview is to explore associations between markers of a
disease and known risk factors, or whether the main
focus is the impact of those risk factors on single or
multiple outcomes. An example overview addressing the
latter purpose is an overview which aimed to evaluate
the strength and validity of the evidence for the associ-
ation between adiposity and risk of developing or dying
from cancer [40]. The authors of this work found strong
evidence of an association between obesity and 11 of the
36 studied cancer sites and subtypes. The cancers for
which there was strong evidence of an association with
obesity were mainly cancers of digestive organs and
female hormone-related malignancies. The authors of
the overview concluded that whilst other associations
could be genuine, substantial uncertainty remains for
the other cancers studied.
Overviews of qualitative reviews
Overviews of reviews of qualitative reviews should be
considered when the objective is to summarise system-
atic review evidence relating to qualitative views or
experiences. There is clear guidance available on the
good conduct of an overview of qualitative syntheses [6],
with commonalities across all types of overviews.
Common features include employing an a priori peer-
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reviewed protocol formed around a clearly pre-specified
research question with detailed inclusion and exclusion
criteria, search strategies and methods for data extrac-
tion and appraisal, followed by clear and replicable
methods for synthesis and summary of included data [6].
An example overview using qualitative data as well as
quantitative information is provided by an overview
exploring improving quality of care for persons with
diabetes looking at a broad range of interventions,
including patient education and support, telemedicine,
organisational changes and outcomes relating to the
process of care [10]. In combining these approaches,
overview authors had potential to synthesise data on pa-
tient experiences of quality of care alongside quantitative
evaluation of effectiveness, which could result in a richer
set of evidence for informing practice and policy.
Whilst many overviews tacitly assess quantitative
outcomes reported in systematic reviews [6], often the
nature of overviews results in narrative synthesis which
can draw on either quantitative or qualitative data within
included systematic reviews. In this sense, many over-
views include elements of qualitative data identified
within the source systematic reviews.
Results and Discussion
There are many similarities between overviews and
systematic reviews, and the principles which guide the
planning of a systematic review (including production of
a clinically-relevant research question and a pre-specified
peer reviewed protocol) are relevant in conducting an
overview [2]. Within this paper, we have described a brief
classification to organise common research questions and
objectives, using overviews based on frameworks devel-
oped within the Cochrane Handbooks for Systematic
Reviews of Interventions [41] and Diagnostic Test Accu-
racy [42]. These descriptions cover overviews of interven-
tion reviews, overviews of diagnostic test accuracy
reviews, overviews of reviews of prognosis/prevalence,
overviews of reviews of risk factors and overviews of
reviews of qualitative studies.
Overviews aim to summarise evidence and to signpost
readers to relevant sources to support decision making;
this paper has highlighted that there are a wide range of
potential reasons for selecting to do an overview, and
that these varied reasons lead to overviews which may
have a number of different methodological features.
Overviews of reviews of different interventions for the
same condition, or of the same intervention but looking
at different outcomes, will have high clinical relevance
where clinical decisions are made between different
treatments. Overviews of intervention reviews, bringing
together evidence relating to the effectiveness of a
specific treatment applied in alternative populations or
settings will be of interest to healthcare providers
delivering that treatment, or to consumers seeking infor-
mation about the effective interventions. Overviews of
risk factors will have similar clinical interest and
potential relevance for policymakers and regulators.
Overviews relating to the adverse effects of an interven-
tion in the same or different conditions may allow com-
monalities to be drawn across a broader range of
evidence than in a more focussed systematic review, with
the potential to highlight equivalence or patterns not
previously identified. Similarly, overviews of systematic
reviews of diagnostic test accuracy provide an opportun-
ity to gain greater insights into test accuracy data sum-
marised across different populations, settings or other
variables, with potential to reduce the impact of data
heterogeneity by drawing on a broader evidence base.
Overviews of prognosis are also increasing in number
and scope, offering potential to provide useful insights
by summarising evidence of the likely course of a condi-
tion, factors associated with health outcomes or identify-
ing risk groups associated with different health
outcomes [38] . When applied within systematic frame-
works, overviews of qualitative evidence provide scope
for creating theoretically-defined conceptions of com-
plex topics [43].
Often, the scope of systematic reviews can be described
as either ‘lumping’ or ‘splitting’ information [44, 45].
Lumping refers to finding commonalities across different
approaches, whereas splitting creates a more narrowly-
refined focus within a broader research field. Systematic
reviews of primary research often split data by addressing
a focussed and specific research question which may
not be very useful for informing broader clinical and
policy decision making. Conversely, overviews com-
monly adopt a ‘lumping’ approach, allowing greater
leeway for generality in research findings [45], and
arguably having greater applicability for policy makers.
There are clearly challenges in ‘lumping’ large volumes
of information, and presenting this in an accessible
format, which is relevant and useful to the end user.
Another significant challenge in lumping information is
how to consistently synthesise such information in the
face of inevitable heterogeneity.
The classification we have employed here suggests a
range of common objectives and research questions
which may be addressed by an overview, where the
primary objective is to summarise the existing body of
systematic review evidence on a topic. The scope of this
summary of evidence is defined by previously stated
inclusion and exclusion criteria [6, 13]. This summary of
evidence should not simply duplicate the reporting of
individual systematic review summaries, but instead
should aim to synthesise across included systematic
review evidence in order to bring new insights to exist-
ing evidence. The suitability of reanalysis of existing data
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within an overview is debated, and it has been argued
that, where novel analyses are the aim, conducting a
review of trials may be more appropriate than an over-
view of reviews [14]. Methodological guidance on the
reporting of systematic reviews using individual partici-
pant data has been published by the PRISMA-IPD
Group [46] and may prove relevant to reporting within
overviews which aim to incorporate novel analyses. It is
clearly important for the stated overview research
questions and objectives to specify any plans for data
analysis, and for this to be planned with reference to the
available methodological guidance, and with appropriate
justification of the use of any overview of reviews, rather
than a review of trials.
At its broadest sense, the common purpose of an over-
view is to provide an accessible summary of evidence, in
order to support decision making by clinicians, policy
makers and developers of clinical guidelines [2]. It is now
widely accepted that in order to ensure relevance and im-
pact of health research, key stakeholders (including but not
restricted to people with a healthcare condition, their fam-
ilies, friends and caregivers, health professionals and deci-
sion makers) should be involved in the process [47, 48].
Central to the conduct of an overview are the people
involved in its production. From formulating the question
to conducting the overview and disseminating findings, the
specific purpose of an overview may change depending on
who is asking the research question and clearly stake-
holders should be actively involved throughout the process.
The involvement of key stakeholders, including patients
and their families or carers, should occur at the earliest
opportunity in order to ensure that the planned overview is
relevant and meaningful to the potential end users of the
overview.
Conclusions
Overviews are a relatively new methodological approach
and consequently a number of aspects of overview
methodology remain uncertain. It is the responsibility of
a research team to decide on their approach before
conducting an overview; central to this is determining
what type of overview is to be conducted. Clear deci-
sions relating to the research questions and objectives to
be addressed by the overview are a fundamental first
step during the initial planning stages for an overview,
and should be developed with the involvement of key
stakeholders. Following best practice, these aspects
should be covered within a published overview protocol
as a mechanism for ensuring transparency and reducing
opportunities for introduction of bias in the conduct of
the overview. Our second paper [5] outlines a number of
key methodological decisions which we consider
important to address when planning an overview, and
which will be important to incorporate within an over-
view protocol.
Despite a need for improved guidance for the conduct
of overviews [2], there are a number of resources available
which support the conduct of overviews [2, 6, 7, 13], and
updates to the relevant chapter of the Cochrane
Handbook are currently in production [7]. Further guid-
ance on the less common types of overview (such as those
addressing reviews of diagnostic tests accuracy and
prognosis) and more challenging aspects of overview pro-
duction, such as methods for narratively synthesising find-
ings, dealing with missing data, poor reporting and
dealing with complexity versus granularity [10], would be
a great benefit to those tackling overviews. In the absence
of empirical evidence to support the selection and imple-
mentation of overview methods, we believe that the use of
illustrated examples of real-life overviews will be helpful
to authors planning new overviews, and to those seeking
to establish evidence relating to optimal overview
methods. This is therefore the focus of our second paper
on this topic [5].
Abbreviations
BMJ: British Medical Journal; HTA: Health Technology Assessment;
PRISMA: Preferred Reporting Items for Systematic Reviews and Meta-Analyses
[systematic review reporting guidelines]; PRISMA-IPD: Preferred Reporting
Items for Systematic Reviews and Meta-Analyses – Individual Patient Data;
PROSPERO: International Prospective Register of Systematic Reviews;
RCTs: Randomised Controlled Trials
Acknowledgements
The views and opinion expressed herein are those of the authors and do
not necessarily reflect those of the funding bodies.
Funding
Research conducted by Harriet Hunt referred to within this paper [38] was
supported as part of doctoral programme funding by the National Institute
for Health Research (NIHR) Collaboration for Leadership in Applied Health
Research and Care South West Peninsula (PenCLAHRC). The overview
conducted by Pollock [3] was supported by a project grant from the Chief
Scientist Office of the Scottish Government. The overview conducted by
McClurg [5] was supported by a project grant by the Physiotherapy Research
Foundation.
Alex Pollock is employed by the Nursing, Midwifery and Allied Health
Professions (NMAHP) Research Unit, which is supported by the Chief
Scientist Office of the Scottish Government. Pauline Campbell is supported
by the Chief Nurses Office of the Scottish Government.
The overview conducted by Estcourt [7] was supported by an NIHR
Cochrane Programme Grant for the Safe and Appropriate Use of Blood
Components.
The overview conducted by Brunton [10] was commissioned by the
Department of Health as part of an ongoing programme of work on health
policy research synthesis.
Availability of data and materials
Not applicable.
Authors’ contributions
HH and AP wrote the original draft, with PC, LE and GB contributing sections
and comments on following drafts of the manuscript. HH wrote the final
manuscript with contributions from AP, PC, LE and GB. All authors read and
approved the final manuscript.
Authors’ information
Not applicable.
Hunt et al. Systematic Reviews  (2018) 7:39 Page 7 of 9
Ethics approval and consent to participate
As this work is an overview of existing systematic reviews and uses
secondary anonymised data without access to individual identifiers, approval
and consent to participate was not required.
Consent for publication
All authors have provided consent for publication.
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Author details
1Exeter Test Group and PenCLAHRC, University of Exeter Medical School, St
Luke’s Campus, Exeter, Devon EX1 1TE, UK. 2Nursing Midwifery and Allied
Health Professions (NMAHP) Research Unit, Glasgow Caledonian University,
Cowcaddens Road, Glasgow G4 0BA, UK. 3Nursing Midwifery and Allied
Health Professions (NMAHP) Research Unit, Glasgow Caledonian University,
Cowcaddens Road, Glasgow G4 0BA, UK. 4NHS Blood and Transplant, Oxford
and Radcliffe Department of Medicine, University of Oxford, Level 2, John
Radcliffe Hospital, Oxford OX3 9BQ, UK. 5UCL Institute of Education,
University College London, 20 Bedford Way, London WC1H 0AL, UK.
Received: 2 February 2017 Accepted: 9 February 2018
References
1. Page MJ, Shamseer L, Altman DG, Tetzlaff J, Sampson M, Tricco AC, Catalá-
López F, Li L, Reid EK, Sarkis-Onofre R, Epidemiology MD. reporting
characteristics of systematic reviews of biomedical research: a cross-sectional
study. PLoS medicine. 2016;13(5):e1002028.
2. Hartling L, et al. A descriptive analysis of overviews of reviews published
between 2000 and 2011. PLoS One. 2012;7(11):e49667.
3. Smith V, Devane D, Begley CM, Clarke M. Methodology in conducting a
systematic review of systematic reviews of healthcare interventions. BMC
Medical Res. Methodology. 2011;11(1):15–21.
4. Lunny C, et al. Toward a comprehensive evidence map of overview of
systematic review methods: paper 1—purpose, eligibility, search and data
extraction. Systematic Reviews. 2017;6(1):231.
5. Pollock A, et al. Selecting and implementing overview methods: implications
from five exemplar overviews. Systematic Reviews. 2017;6(1):145.
6. Aromataris E, et al. Summarizing systematic reviews: methodological
development, conduct and reporting of an umbrella review approach. Int J
Evidence-Based Healthcare. 2015;13(3):132–40.
7. Becker, L. and A. Oxman, Chapter 22: Overviews of reviews., in Cochrane
Handbook for Systematic Reviews of Interventions Version 5.1.0 H. JPT and
G. S, Editors. 2011, The Cochrane Collaboration.
8. Pieper D, Antoine SL, Morfeld JC, Mathes T, Eikermann M. Methodological
approaches in conducting overviews: current state in HTA agencies. Res
Synthesis Methods. 2014;5(3):187–99.
9. Lunny C, Brennan SE, McDonald S, McKenzie JE. Evidence map of studies
evaluating methods for conducting, interpreting and reporting overviews of
systematic reviews of interventions: rationale and design. Systematic
reviews. 2016;5(1):4.
10. Worswick J, et al. Improving quality of care for persons with diabetes: an
overview of systematic reviews—what does the evidence tell us?
Systematic Reviews. 2013;2(1):26.
11. Caird J, et al. Mediating policy-relevant evidence at speed: are systematic reviews
of systematic reviews a useful approach? Evidence Policy. 2015;11(1):81–97.
12. Whitlock EP, et al. Using existing systematic reviews in complex systematic
reviews using existing systematic reviews in complex systematic reviews.
Ann Intern Med. 2008;148(10):776–82.
13. Pollock M, et al. What guidance is available for researchers conducting
overviews of reviews of healthcare interventions? A scoping review and
qualitative metasummary. Systematic Reviews. 2016;5(1):190–205.
14. Hartling L, et al. Comparing multiple treatments: an introduction to
overviews of reviews. In 23rd Cochrane Colloquium: Filtering the
information overload for better decisions. Vienna: Wiley; 2015.
15. Ballard M, Montgomery P. Risk of bias in overviews of reviews: a scoping
review of methodological guidance and four-item checklist. Res Synthesis
Methods. 2017;8
16. Pieper D, Buechter R, Jerinic P, Eikermann M. Overviews of reviews often have
limited rigor: a systematic review. J Clin Epidemiol. 2012;65(12):1267–73.
17. Thomson D, Foisy M, Oleszczuk M, Wingert A, Chisholm A, Hartling L.
Overview of reviews in child health: evidence synthesis and the
knowledge base for a specific population. Evidence-Based Child Health:
A Cochrane Rev J. 2013;8(1):3–10.
18. Pollock A, et al. Cochrane overviews of reviews: exploring the methods and
challenges. Birmingham: UK and Ireland Cochrane Symposium; 2016.
19. Hoving JL, et al. Work participation and arthritis: a systematic overview of
challenges, adaptations and opportunities for interventions. Rheumatology.
2013;52(7):1254–64.
20. de Rezende LFM, et al. Sedentary behavior and health outcomes: an overview
of systematic reviews. PLoS One. 2014;9(8):e105620.
21. McClurg D, et al. Conservative interventions for urinary incontinence in women:
an overview of Cochrane systematic reviews. Cochrane Database Syst Rev. 2016;9
22. Pollock A, et al. Interventions for improving upper limb function after stroke.
Cochrane Database Syst Rev. 2014;11
23. Brunton G, et al. Developing evidence-informed, employer-led workplace
health. London: EPPI-Centre, Social Science Research Unit, UCL Institute of
Education, University College London; 2016.
24. Harris J, et al. How stakeholder participation can contribute to systematic
reviews of complex interventions. J Epidemiol Community Health. 2016;
70(2):207–14.
25. Estcourt LJ, et al. Red blood cell transfusion to treat or prevent complications
in sickle cell disease: an overview of Cochrane reviews. Cochrane Database of
Syst Rev. 2016;2
26. Cates CJ, Oleszczuk M, Stovold E, Wieland LS. Safety of regular formoterol or
salmeterol in children with asthma: an overview of Cochrane reviews.
Cochrane Database Syst Rev. 2012;(10):CD010005. https://doi.org/10.1002/
14651858.CD010005.pub.
27. Castle W, et al. Serevent nationwide surveillance study: comparison of
salmeterol with salbutamol in asthmatic patients who require regular
bronchodilator treatment. BMJ. 1993;306(6884):1034–7.
28. Nelson HS, et al. The salmeterol multicenter asthma research trial: a
comparison of usual pharmacotherapy for asthma or usual
pharmacotherapy plus salmeterol. CHEST J. 2006;129(1):15–26.
29. Gillespie DC, Bowen A, Chung CS, Cockburn J, Knapp P, Pollock A.
Rehabilitation for post-stroke cognitive impairment: an overview of
recommendations arising from systematic reviews of current evidence. Clin
Rehabil. 2015;29(2):120–8.
30. Zorzela L, Loke YK, Ioannidis JP, Golder S, Santaguida P, Altman DG, Moher
D, Vohra S. PRISMA harms checklist: improving harms reporting in
systematic reviews. BMJ. 2016;352:i157.
31. Frieden TR. Evidence for health decision making—beyond randomized,
controlled trials. N Engl J Med. 2017;377(5):465–75.
32. Berlin JA, Glasser SC, Ellenberg SS. Adverse event detection in drug
development: recommendations and obligations beyond phase 3. Am J
Public Health. 2008;98(8):1366–71.
33. Loke YK, et al. Systematic reviews of adverse effects: framework for a
structured approach. BMC Med Res Methodol. 2007;7:32.
34. Posadzki P, Watson LK, Ernst E. Adverse effects of herbal medicines: an
overview of systematic reviews. Clin Med (Lond). 2013;13(1):7–12.
35. Bossuyt P, et al., Chapter 11: Interpreting results and drawing conclusions. In:, in
Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy Deeks
JJ, Bossuyt PM, and Gatsonis C, Editors. 2013, The Cochrane Collaboration.
36. Mocellin S, Pasquali S. Diagnostic accuracy of endoscopic ultrasonography
(EUS) for the preoperative locoregional staging of primary gastric cancer.
Cochrane Database Syst Rev. 2015;2
37. Hunt, H., E. Kuzma, and H. C, A review of existing systematic reviews summarising
the accuracy of brief cognitive assessments for identifying dementia, particularly
for use in primary care. Protocol., in PROSPERO 2016: PROSPERO online.
38. Williams, K. and C. Moons. An Introduction to Systematic Reviews of
Prognosis. [Powerpoint presentation] 2012; Available from: https://www.
google.co.uk/url?sa=t&rct=j&q=&esrc=s&source=web&cd=1&cad=rja&uact=
8&ved=0ahUKEwixm4Pz-6fZAhWQZlAKHbntBR8QFggxMAA&url=
http%3A%2F%2Fmethods.cochrane.org%2Fsites%2Fmethods.cochrane.org.
prognosis%2Ffiles%2Fpublic%2Fuploads%2FAuckland%2520presentation_p.
Accessed 15 Feb 2018.
Hunt et al. Systematic Reviews  (2018) 7:39 Page 8 of 9
39. Santaguida L, et al. A description of the methodology used in an overview
of reviews to evaluate evidence on the treatment, harms, diagnosis/
classification, prognosis and outcomes used in the management of neck
pain. Open Orthopaedics. 2013;7(Suppl 4 : M2):461–72.
40. Kyrgiou M, et al. Adiposity and cancer at major anatomical sites: umbrella
review of the literature. BMJ. 2017;356
41. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews
of Interventions Version 5.1.0 [updated March 2011]. The Cochrane
Collaboration, 2011. Available from http://handbook.cochrane.org.
42. Deeks JJ, Bossuyt PM, and Gatsonis C, Cochrane Handbook for Systematic
Reviews of Diagnostic Test Accuracy 2013, The Cochrane Collaboration:
Available from: http://methods.cochrane.org/sdt/. Accessed 15 Feb 2018.
43. Gentles SJ, et al. Reviewing the research methods literature: principles and
strategies illustrated by a systematic overview of sampling in qualitative
research. Systematic Reviews. 2016;5(1):172.
44. Weir MC, et al. Decisions about lumping vs. splitting of the scope of
systematic reviews of complex interventions are not well justified: a case
study in systematic reviews of health care professional reminders. J Clin
Epidemiol. 2012;65(7):756–63.
45. Baker PR, et al. The benefits and challenges of conducting an overview of
systematic reviews in public health: a focus on physical activity. J Public
Health. 2014;36(3):517–21.
46. Stewart LA, et al. Preferred reporting items for a systematic review and
meta-analysis of individual participant data: the PRISMA-IPD statement.
JAMA. 2015;313(16):1657–65.
47. INVOLVE Exploring the impact of public involvement on the quality of
research: examples. 2013.
48. Kreis J, et al. Consumer involvement in systematic reviews of comparative
effectiveness research. Health Expect. 2013;16(4):323–37.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Hunt et al. Systematic Reviews  (2018) 7:39 Page 9 of 9
